Legal & General Group PLC Trevena Inc Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.16 - $100.0 $2,090 - $1.31 Million	-13,066 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$0.2 - $0.5 $283 - $709	-1,418 Reduced 9.79%	13,066 $5,000
Q2 2021 Aug 12, 2021	BUY	$1.46 - $2.25 $21,146 - $32,589	14,484 New	14,484 $24,000
Q2 2018 Aug 10, 2018	SELL	$1.44 - $2.24 $18,148 - $28,230	-12,603 Closed	0 $0
Q1 2018 May 17, 2018	SELL	$1.51 - $2.06 $7,610 - $10,382	-5,040 Reduced 28.57%	12,603 $21,000
Q4 2017 Feb 13, 2018	BUY	$1.4 - $2.6 $24,700 - $45,871	17,643	17,643 $29,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.